$RVV $RVVTF - cut & paste post as usual .. from Yahoo !"starting a trial for severe covid, the update never said that, it just said the current phase 3 clincial trial ''will position Bucillamine as a potential oral treatment option for mild-moderate to severe COVID-19'' this update is even better than expected and i reckon nearly as good as EUA, the FDA just expanded the trail parameters because bucillamine is obviously working, just how good are those thiols at working against this life sucking covid 19??? All the research is pointing at this being the real deal. this + the way the chart is looking / we are retesting the breakout above .485 downward trend yday, if we hold that at + .49 we are flying it, and could get some serious gap ups very soon. When this gets even more institutional (cannacord etc) and retail hype, + EUA covid vaccine or viral approval, we will be +$10 i reckon, if OCGN can do it on less,we should be able to the same if not surpass it in similar mkt environment..... glta"